UBM India will organise a three-day strategic summit which will bring together US FDA, MHRA and Lachman consultants at the 3rd Annual Global Pharma Regulatory Summit to be held in Mumbai from April 23 to 25, 2014.
The summit will focus on the new and updated guidelines introduced by the prominent regulatory bodies around the globe. Top regulators including Dr Sumit sen, US FDA, Dr Anjana Agarwal, Senior Assessor, MHRA, Fran Zipp, President, Lachman Consultants & Brijesh Patel, Ex-MHRA will address and resolve the concerns from the regulatory perspective.
Some of the important topics being discussed at this regulatory summit include analytical methodologies on reducing and controlling metallic and elemental impurities refuse to receive guidelines, regulatory and procedural guidelines to support the implementation of variations guidelines.
The summit has already attracted more than 120 delegates from companies like Cipla, Sun Pharma, Dr Reddy’s Laboratories, Piramal Enterprises, Glenmark Generics, Jubilant Life sciences, GlaxoSmithKline Asia, Zydus Cadila, USV and many more.
EP News Bureau – Mumbai